| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |